MARKET

NVAX

NVAX

Novavax Inc
NASDAQ
6.57
-0.12
-1.79%
Closed 19:59 12/12 EST
OPEN
6.70
PREV CLOSE
6.69
HIGH
6.71
LOW
6.43
VOLUME
2.93M
TURNOVER
0
52 WEEK HIGH
11.55
52 WEEK LOW
5.01
MARKET CAP
1.07B
P/E (TTM)
3.653
1D
5D
1M
3M
1Y
5Y
1D
Novavax (NVAX) Valuation Check as FDA Scrutiny Rises and Activist Pushes for Possible Sale
Simply Wall St · 1d ago
FDA Weighs Black Box Warning For COVID Vaccines, Experts Push Back
Benzinga · 2d ago
FDA plans to put “black box” warning on Covid vaccines: report
Seeking Alpha · 2d ago
CDC study finds COVID shot significantly reduced ER visits for children
Seeking Alpha · 3d ago
Why I Wouldn't Touch Novavax With a 10-Foot Pole
The Motley Fool · 3d ago
Debate On Vaccine Safety Reaches Policy Stage - FDA Broadens Review Into Covid-19 Shot Risks In Adults
Benzinga · 4d ago
FDA expands COVID-19 shot safety probe to include adults - report
Seeking Alpha · 5d ago
U.S. Dept. Of Health And Human Services Says "Doing A Thorough Investigation, Across Multiple Age Groups, Of Deaths Potentially Related To Covid Vaccines"
Benzinga · 5d ago
More
About NVAX
Novavax, Inc. is a biotechnology company. It is focused on addressing global health challenges through its vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. Matrix-M can be used to create vaccines for a variety of diseases to help tackle some of the pressing health challenges. Its proprietary Matrix-M adjuvant, when added to vaccines, has been shown to help induce a stronger and longer-lasting immune response. Its recombinant protein-based nanoparticle technology has been shown to be highly immunogenetic. Its technology platform is used in its authorized COVID-19 vaccine and the R21/Matrix-M adjuvant malaria vaccine. Its late-stage programs include a COVID-19-Influenzavaccine candidate, and an influenza vaccine candidate. R21/Matrix-M adjuvant malaria vaccine, a malaria vaccine developed by its partner. It provides Matrix-M adjuvant for use in various programs in preclinical and clinical stage, and preclinical investigations.

Webull offers Novavax Inc stock information, including NASDAQ: NVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVAX stock methods without spending real money on the virtual paper trading platform.